Bevacizumab Works in Triple-Negative Breast Cancer SubtypeBevacizumab Works in Triple-Negative Breast Cancer Subtype

New results could reignite interest in the use of bevacizumab in breast cancer, especially in a subtype of triple-negative disease. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news